FDA Inspection 1218220 — Hetero Labs Ltd. Unit VI

Hetero Labs Ltd. Unit VI — FEI 3008294355

The FDA completed an inspection of Hetero Labs Ltd. Unit VI on September 21, 2023 in Mahaboob Nagar. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 21, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Mahaboob Nagar (India)